Deep Brain Stimulation (DBS) to treat tremor in people with Parkinson’s was approved by the FDA in 1997. Then in 2002, it was approved to treat advanced symptoms of Parkinson’s. For many years, people thought DBS was only for people who were very advanced. That’s not the case. There are many who have only been living with Parkinson’s for a few years who are great candidates for DBS. DBS has the power to reduce or eliminate OFF times, reduce the frequency and dose of medications, and dramatically improve quality of life.
This webinar covered the what, when, why, how, and more of DBS from movement disorder specialists who recommend it, surgeons who perform it, companies that make the devices, and someone who has been living with it for over 10 years.
In this webinar, the panel discussed:
- The goals of DBS and how it works
- About the different types of DBS systems (including the different types of batteries)
- What symptoms DBS does and does not help
- How quickly and how well symptoms respond to DBS over the long term
- The biggest myths or misunderstandings about DBS
- How to blend DBS and medication and what to expect over time
- How the approval/evaluation process works
- About the ethical implications/dilemmas related to DBS
- How programming works, potential challenges related to programming, and what to expect
- Developments and innovation in DBS
If you live outside of the U.S. or Canada and would like to receive recording, click here.
Sign up to Get the Recording:
Dr. Soania Mathur
Dr. Helen Brontë-Stewart
Dr. Kelly Foote
Dr. Aaron Haug
Dr. Francisco Ponce
Dr. Stephen Carcieri
Dr. Lisa M. Johanek
This webinar is sponsored* by Boston Scientific and Medtronic.
*While the generous support of our sponsors makes our educational programs available,
their donations do not influence Davis Phinney Foundation content, perspective, or speaker selection.